Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway.

Wu LM, Liao XZ, Zhang Y, He ZR, Nie SQ, Ke B, Shi L, Zhao JF, Chen WH

DOI: 10.3389/fcell.2020.610097
Published: 2020
Container: Frontiers in cell and developmental biology
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fcell.2020.610097,
  title = {Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway.},
  author = {Wu LM and Liao XZ and Zhang Y and He ZR and Nie SQ and Ke B and Shi L and Zhao JF and Chen WH},
  year = {2020},
  journal = {Frontiers in cell and developmental biology},
  doi = {10.3389/fcell.2020.610097},
  url = {https://doi.org/10.3389/fcell.2020.610097}
}

RIS

TY  - JOUR
TI  - Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway.
AU  - Wu LM
AU  - Liao XZ
AU  - Zhang Y
AU  - He ZR
AU  - Nie SQ
AU  - Ke B
AU  - Shi L
AU  - Zhao JF
AU  - Chen WH
PY  - 2020
JO  - Frontiers in cell and developmental biology
DO  - 10.3389/fcell.2020.610097
UR  - https://doi.org/10.3389/fcell.2020.610097
ER  -

APA

LM, W., XZ, L., Y, Z., ZR, H., SQ, N., B, K., L, S., JF, Z., & WH, C. (2020). Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway.. Frontiers in cell and developmental biology. https://doi.org/10.3389/fcell.2020.610097

Source records

pubmed · retrieved 2026-09-25T11:03:07.878Z